We use cookies to give you the best online experience. By using our website you agree to our use of cookies in accordance with our cookie policy.

list of NY corporations

Biogen’s Alzheimer’s drug is unlikely to win E.U. approval.


The drug, Aduhelm, has been mired in controversy since it was in approved in the United States in June.
read more

Source: NY Times


20:23, November 17, 2021 Rebecca Robbins

You may also like

News